Clinical scofflaws?

These 30 sponsors of clinical trials failed to submit results by the legal deadline, or at all within the 20-month window Science examined, for all of their studies. For the 216 trials that were due, results for two-thirds were still unreported as of 25 September 2019, the end of that window. Only 17% of the 216 trials had submitted results that passed National Institutes of Health quality control and appear on ClinicalTrials.gov. This list includes only sponsors with at least five due trials.

Sponsor – number of trials

  • Abramson Cancer Center, University of Pennsylvania – 11
  • Acerta Pharma – 7
  • Actavis – 6
  • Barbara Ann Karmanos Cancer Institute – 5
  • Baylor College of Medicine – 13
  • Boston Children’s Hospital – 5
  • Braeburn Pharmaceuticals – 5
  • Cairo University – 10
  • Case Comprehensive Cancer Center – 11
  • Cutera Inc. – 11
  • Edwards Lifesciences – 8
  • Fox Chase Cancer Center – 7
  • GTx – 6
  • Jonsson Comprehensive Cancer Center, University of California, Los Angeles – 5
  • Lundquist Institute for Biomedical Innovation – 5
  • Medical College of Wisconsin – 6
  • Medstar Health Research Institute – 5
  • Northwell Health – 7
  • Otonomy – 5
  • Pacira Pharmaceuticals – 5
  • St. Joseph’s Hospital and Medical Center – 5
  • The Cooper Health System – 5
  • University of Texas, Dallas – 6
  • University Hospitals Cleveland Medical Center – 6
  • University of Cincinnati – 8
  • University of Maryland, College Park – 7
  • University of Minnesota – 14
  • University of Nebraska – 5
  • University of South Florida – 7
  • University of Southern California – 10